Although the insulinotropic effect of GIP is diminished in patients with type 2 diabetes, studies have found that GIP receptor agonists can induce a degree of weight loss and, when used in combination with GLP-1, can produce synergistic effects, enhancing blood glucose reduction and weight loss
References European Journal of Anaesthesiology Delta sleep-inducing peptide: discovery, structure, and pharmacological overview Neuroscience & Biobehavioral Reviews (PubMed) Delta-sleep-inducing peptide (DSIP): a review of sleep-promoting and neuromodulatory effects European Neurology (PubMed) Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia European Neurology (PubMed) DSIP in insomnia: timing and frequency of administration in clinical trials Tocris Bioscience Stability and storage guidelines for research peptides MedlinePlus (U.S
Whether you're a strength athlete, endurance competitor, or simply an active adult, the Setria + citrulline combination can provide benefits
Low-dose aspirin prevents hypertension and cardiac fibrosis when thromboxane A 2 is unrestrained
Typically injected at night, five nights per week, under medical supervision for optimal hormone rhythm support
Hair loss is emerging as a possible side effect of GLP-1 drugs